| Non‐serious adverse events | ||
|---|---|---|
| Study | Symptom | Adverse events/total number of participants |
| Altin 2013 | Total adverse events | 21/142 |
| Ardic 2014 | Any adverse event (with OROS (osmotic controlled release oral delivery system) methylphenidate) | 52/122 |
| Arnold 2004 | Any adverse event | 76/76 |
| Atzori 2009 | Total number of patients who experience adverse events | 54/134 |
| Barrickman 1995 | Total adverse events | 5/15 |
| Berek 2011 | Total adverse events | 195/762 |
| Chou 2012b | Total adverse events | 95/230 |
| Cortese 2015 | Total adverse events | 369/1426 |
| Dirksen 2002 | Total adverse events | 78/287 |
| Dittmann 2014 | Total adverse events | 25/195 |
| Döpfner 2011a, OBSEER | Total adverse events | 209/822 |
| Döpfner 2011b | Total adverse events | 40/106 |
| Findling 2010 | Total adverse events | 68/88 |
| Garg 2014 | Total adverse events | 18/27 |
| Gau 2008 | Total adverse events | 180/607 |
| Gerwe 2009 | Total adverse events | 160/263 |
| Goez 2012 | Total adverse events | 7/28 |
| Green 2011 | Total adverse events | 14/14 |
| Greenberg 1987 | Total adverse events | 8/49 |
| Greenhill 1983 | Total adverse events | 5/7 |
| Gucuyener 2003 | Total adverse events | 26/119 |
| Haertling 2015 | Total adverse events | 27/239 |
| Hammerness 2009 | Total adverse events | 45/57 |
| Hammerness 2012 | Total adverse events | 0/27 |
| Haubold 2010 | Total adverse events | 32/103 |
| Jensen 1999 (MTA) | Total adverse events | 150/245 |
| Karabekiroglu 2008 | Total adverse events | 28/90 |
| Khajehpiri 2014 | At least one adverse drug reaction | 71/71 |
| Kim 2015b | Total adverse events | 8/116 |
| Kordon 2011 | Total adverse events | 172/541 |
| Lee 2014 | Total adverse events | 3513/4055 |
| Lyon 2010 | Total adverse events | 7/10 |
| Mayes 1994 | Total adverse events | 35/63 |
| McCracken 2016 | Total adverse events | 58/60 |
| Na 2013 | Total number of patients who experienced adverse events | 98/103 |
| Remschmidt 2005 | Total adverse events | 76/89 |
| Schulz 2010 | Total adverse events | 36/145 |
| Sobanski 2013 | Total adverse events | 26/347 |
| Song 2012 | Total adverse events | 116/116 |
| Su 2015 | Total adverse events | 101/205 |
| Tasdelen 2015 | Total adverse events | 12/17 |
| Valdizán Usón 2013 | Total adverse events | 177/689 |
| Warshaw 2010 | Total adverse events | 242/260 |
| Weiss 2007 | Total adverse events | 64/79 |
| Wigal 2013 | Total adverse events | 42/45 |
| Wilens 2005 | Total adverse events | 344/407 |
| Wilens 2006 | Total adverse events | 96/135 |
| Yatsuga 2014 | Total adverse events | 7/50 |
| Zheng 2015 | Total adverse events | 24/123 |